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Abstract 1 
A growing body of work in social and affective neuroscience suggests that 2 
emotion plays an instrumental role in error monitoring processes, rather than only 3 
a moderating one. High-powered replications of studies that support this idea, 4 
however, are lacking. Here, we attempted a preregistered replication of our own 5 
study that had provided evidence for the functional role of emotions in error 6 
monitoring: that a neural signal of error monitoring—the error-related negativity—7 
is reduced when participants undergo a misattribution of arousal procedure 8 
(Inzlicht & Al-Khindi, 2012). Like a previous replication attempt (Rodilla, 9 
Beauducel, & Leue, 2016), our misattribution procedure failed to reduce the 10 
amplitude of the ERN. However, it also failed its manipulation check to reduce 11 
state anxiety, limiting the conclusions we can draw. Nonetheless, these findings 12 
are consistent with the view that our original study may have been a false 13 
positive. We discuss these findings in the context of the replication crisis in 14 
psychology and of work on the emotional properties of the ERN. 15 
 16 
Keywords: ERN; emotion; misattribution; anxiety; replication 17 18 
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Introduction 1 
Monitoring performance for errors is important for day-to-day functioning. Errors 2 
can impede or prevent progress toward desired goal states, and failures to detect 3 
or adjust for errors in performance can have consequences of physical, social, 4 
and economic import. Errors while driving vehicles or performing surgery, for 5 
example, can have fatal consequences. Although research over the past two 6 
decades has done much to advance our understanding of the cognitive and 7 
neural systems that support error monitoring, there remains a dearth of literature 8 
on the role of emotions and motivation in error detection and compensation. 9 
Here, we seek to replicate Inzlicht and Al-Khindi (2012), our own previous study 10 
that provided experimental evidence that emotions contribute to error monitoring: 11 
the finding that a neural signal called the error-related negativity (ERN) is 12 
reduced when participants misattribute their emotions to a placebo. 13 
The ERN 14 
 In electroencephalography, the ERN is a negative deflection in the event-15 
related potential (ERP) that occurs within 100 ms of error responses over 16 
frontocentral electrode sites, and is thought to be generated in the dorsal regions 17 
of the medial frontal cortex (Dehaene, Posner, & Tucker, 1994; Pourtois et al., 18 
2010; Van Veen & Carter, 2002). While the functional significance of the ERN 19 
remains a topic of debate, a number of computational theories have proposed 20 
that the component represents conflict monitoring (Yeung, Botvinick, & Cohen, 21 
2004), reinforcement learning (Holroyd & Coles, 2002), or error likelihood (Brown 22 
& Braver, 2005). Recent work has also described ERN amplitudes as 23 
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representing to the affective, motivational, or evaluative aspects of errors (Aarts, 1 
De Houwier, & Pourtois, 2013; Proudfit, Inzlicht, & Menin, 2013; Weinberg, 2 
Riesel, & Hajcak, 2012). Consistent with this perspective, ERN amplitude 3 
become larger when task performance is incentivized or punished (Legault & 4 
Inzlicht, 2013; Pailing & Segalowitz, 2004; Riesel, Weinberg, Endrass, 5 
Kathmann, & Hajcak, 2012), and when participants focus on affect during 6 
performance (Saunders, Rodrigo & Inzlicht, 2016). Conversely, ERN amplitude is 7 
reduced when negative emotions are attenuated through cognitive reappraisal 8 
(Hobson, Saunders, Al-Khindi, & Inzlicht, 2014) or through the consumption of 9 
alcohol (Ridderinkhof et al., 2002; Bartholow, Henry, Lust, Saults, & Wood, 10 
2012). ERN amplitude also increases as a function of trait anxiety (Hajcak, 11 
McDonald, & Simons, 2003; Meyer, Weinberg, Klein, & Hajcak, 2012; Pourtois et 12 
al., 2010) and trait negative affect (e.g., Luu, Collins, & Tucker, 2000; Luu, 13 
Flaisch, & Tucker, 2000), and either increases or decreases as a function of 14 
clinical status (e.g., Gehring, Himle, & Nisenson, 2000; Weinberg, Olvet, & 15 
Hajcak, 2010; Xiao et al., 2010). These findings have led researchers to propose 16 
that the ERN reflects—at least in part—the degree to which errors are 17 
motivationally significant or endogenously threatening (Aarts et al., 2013; Proudfit 18 
et al., 2013; Weinberg et al., 2012; Weinberg et al., 2016). 19 
Misattribution and the ERN 20 
In our original study (Inzlicht and Al-Khindi, 2012), we had investigated 21 
how ERN amplitude and task performance would be influenced by a 22 
misattribution of arousal paradigm. Since the 1960s, researchers have shown 23 
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that the source of emotions can be misattributed, and that misattribution can alter 1 
the quality, magnitude, and labeling of emotional experiences (Reisenzein, 1983; 2 
Schacter & Singer, 1962). Indeed, classic studies from social psychology have 3 
shown that the intensity of emotional experiences is reduced when individuals 4 
misattribute their emotions to a benign, external source (Ross, Rodin, & 5 
Zimbardo, 1969; Zanna & Cooper, 1974). When patients with insomnia were 6 
instructed to consume a sugar pill, for example, those who were told the pill 7 
would make them feel anxious fell asleep faster than those who were told the pill 8 
would make them feel relaxed (Storms & Nisbett, 1970). Ostensibly, patients in 9 
the former group experienced less anxiety because they could attribute at least 10 
some of their restlessness to the pill, while patients in the latter group could only 11 
attribute their restlessness to their own thoughts and feelings. 12 
Accordingly, the original study investigated whether ERN amplitude would 13 
be reduced under the effects of misattribution. We reasoned that if the ERN 14 
reflects an affective response to mistakes, its amplitude would be reduced when 15 
participants had the opportunity to misattribute their emotions to something other 16 
than their own task performance (i.e., the placebo). In an initial pilot study, we 17 
found that state anxiety was increased after performing a task, and that this 18 
increase was smaller for the misattribution group (M = 1.97, SD = 0.58) 19 
compared to the control group (M = 2.29, SD = 0.39), t(46) = 2.16, p = 0.036, d = 20 
0.64. In the main study, we repeated the misattribution paradigm while 21 
measuring the ERN. We found that ERN amplitudes were smaller in the 22 
misattribution group (M = -3.92 μV, SD = 2.18) compared to the control group (M 23 
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= -6.52 μV, SD = 3.96), F(1, 34) = 6.12, p = 0.019, η2p = .15. We also found that 1 
error rates were negatively correlated with the magnitude of the ΔERN (the ERN 2 
minus the correct trial equivalent; the correct-related negativity, CRN) in the 3 
control group (r = .54, p = 0.02) and not the misattribution group (r = .19, p = .44), 4 
although this difference was not significant between groups. In both the pilot and 5 
main studies, task performance and performance expectations were not 6 
significantly different between groups. 7 
With less ambiguity than previous studies, these findings provided 8 
evidence of the emotional characteristics of the ERN. Without altering task 9 
performance or performance expectations, the study’s misattribution paradigm 10 
was successful in reducing both state anxiety and ERN amplitudes. Further, a 11 
significant relationship between ERN amplitudes and error rates was present in 12 
the control group, but not in the misattribution group. Although the relationship 13 
between the ERN amplitudes and behavioral measures is unclear (see Weinberg 14 
et al., 2012), these findings implied that the ERN’s association with task 15 
performance may be dependent on whatever processes are altered by 16 
misattribution; at least some of these processes are probably emotional in 17 
nature. In short, we had found compelling evidence that the ERN has emotional 18 
properties. 19 
The Present Study 20 
The results from Inzlicht and Al-Khindi (2012) should be replicated for 21 
several conceptual, statistical, and practical reasons. Firstly, despite the original 22 
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paper having more than 80 citations to date1, only one recent study constitutes a 1 
replication attempt of the original study (Rodilla, Beauducel, & Leue, 2016). 2 
Given the recent attention to replication attempts of many seminal findings in 3 
psychology (e.g., Open Science Collaboration, 2015), it would be prudent to try 4 
further replicating one of the first studies to clearly demonstrate the emotional 5 
properties of the ERN. In the single replication attempt, Rodilla et al. (2016) failed 6 
to find any differences in ERN amplitudes across misattribution and control 7 
groups while using a between-subjects design with high power. They also did not 8 
observe any differences across groups for self-reported anxiety; both 9 
misattribution and control groups experienced an equal increase in anxiety from 10 
before the task to after the task. This failure to replicate may have occurred 11 
because the authors used only the information available in the original 12 
publication, and did not contact the original authors for complete experimental 13 
protocols and procedures. If there is a true difference in ERN amplitudes 14 
between misattribution and control conditions—and the replication attempt did 15 
not constitute a Type II error (i.e., a false negative)—it may be the case that the 16 
divergent findings between these studies are the result of differences in their 17 
respective methodologies. If this is the case, then a replication attempt with full 18 
information should be made to elucidate what factors might be influencing this 19 
divergence. 20 
Our original experiment should also be replicated because of its low 21 
statistical power. We made use of a between-subjects design with less than 20 22 
                                                             1 As assessed on Google Scholar, June 2018. 
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individuals in each group. This low sample size limited the study’s ability to detect 1 
any true small- or medium-size effect, while simultaneously being more 2 
susceptible to experimenter degrees of freedom that could inflate the probability 3 
of false positive results. 4 
Lastly, new perspectives on the function of the ERN may make an even 5 
stronger argument for the results reported in the original study than the reasoning 6 
we originally provided for it. If the ERN at least partially signifies the motivational 7 
significance of errors (Aarts, De Houwer, Pourtois, 2013; Proudfit, Inzlicht, & 8 
Mennin, 2013) or trait defensive reactivity to errors (Weinberg et al., 2012), then 9 
the misattribution paradigm may constitute an exceptionally pertinent 10 
manipulation of how endogenously threatening participants find errors to be 11 
during task performance. Under the conditions of misattribution, emotional 12 
experiences that would typically be attributed to the self—like failures and 13 
successes in task performance—are instead attributed to an exogenous, benign 14 
placebo. Consequently, errors under misattribution should be perceived as less 15 
self-caused and less threatening than typical errors. Accordingly, the efficacy of 16 
the misattribution paradigm may depend on individual differences in body 17 
consciousness (Brockner & Swap, 1983; Heatherton, Polivy, & Herman, 1989) 18 
and self-perception (Duncan & Laird, 1980), where high self-awareness is related 19 
to a typical effect of a misattribution, while low self-awareness is related to 20 
nonsignificant or reversed effects of misattribution (i.e., a typical placebo effect). 21 
Thus, to the extent that ERN amplitudes represents an affective or defensive 22 
response to errors, it should be reduced when a misattribution paradigm 23 
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diminishes how endogenously threatening participants perceive their errors to be. 1 
Therefore, we attempted to replicate our previous study while employing a 2 
more statistically powerful design and while using more appropriate statistical 3 
procedures. By combining a repeated-measures design with multi-level 4 
modelling, the present replication had higher statistical power to detect 5 
differences across conditions compared to the original experiment. Further, by 6 
pre-registering our hypotheses and analysis plans, we increased our error control 7 
and reduced the likelihood of inflated Type I errors. 8 
Hypotheses 9 
1. Both the ERN and ΔERN amplitudes will be less negative when 10 
participants have the opportunity to misattribute their emotions to a 11 
placebo during the task, compared to their performance when they do not 12 
have the opportunity to misattribute their emotions to the placebo. 13 
In the original experiment that used a between-subjects design, both ERN 14 
and ΔERN amplitudes were smaller in the Misattribution group compared to the 15 
Control group. In the present replication, we will compare ERN and ΔERN 16 
amplitudes both between and within participants, who will perform the task both 17 
with and without the placebo (see Methods for details). For participants in the 18 
Misattribution group, we hypothesize that the amplitudes of the ERN and ΔERN 19 
will be reduced when participants perform under the perceived anxiogenic effects 20 
of the placebo, compared to when they perform while not under the perceived 21 
effects of the placebo. Conversely, for participants in the Control group, we 22 
hypothesize that ERN and ΔERN amplitudes will be the same or larger (i.e., 23 
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more negative) when participants perform under the perceived effects of the 1 
placebo, compared to when they perform while not under the perceived effects of 2 
the placebo. 3 
2. State anxiety will rise after participants perform the task under the 4 
effects of the placebo, but this increase will be reduced for participants in 5 
the Misattribution condition compared to the Control condition.  6 
In the original pilot study, participants in both the Misattribution and 7 
Control groups experienced greater anxiety after performing the task. However, 8 
this rise was smaller in the Misattribution group compared to the Control group. 9 
Accordingly, we expect that participants will have greater state anxiety after 10 
performing the task compared to before it, and this rise will not be as large for 11 
participants in the Misattribution group compared to the Control group. Further, 12 
participants will perform the task twice in a counterbalanced fashion, so the 13 
second time they perform the task they will be less likely to experience a change 14 
in anxiety from before the task to after it. Thus, we will also ask participants about 15 
their state emotions related specifically to task performance, with the same 16 
expectations as those in the original study: Participants in both Control and 17 
Misattribution groups will experience a rise in state anxiety about task 18 
performance after the task compared to before it, and this increase will be 19 
reduced for participants in the Misattribution group compared to the Control 20 
group. 21 
3. There will be no direct effect of group or condition on behavioural 22 
performance (i.e., no-go error rates) or performance expectations. 23 
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However, there may be an indirect effect of group on error rates through 1 
the ERN/ΔERN, such that reduced ERN/ΔERN amplitudes in the 2 
Misattribution group will predict higher error rates. In general, we anticipate 3 
that ERN/ΔERN amplitudes will be negatively correlated with error rates, 4 
but significantly less so for participants under the effects of the placebo in 5 
the Misattribution group compared to performance under the effects of the 6 
placebo in the Control group. 7 
In the original experiment, participants in both groups had no significant 8 
differences in no-go error rates and performance expectations, despite significant 9 
differences in state anxiety and ERN amplitudes. ΔERN amplitudes were also 10 
negatively correlated with error rates in the Control group and not the 11 
Misattribution group, although difference between the groups for this relationship 12 
was not significant. Accordingly, we hypothesize that no-go error rates and 13 
performance expectations will not be significantly different across groups and 14 
conditions, and that ERN/ΔERN amplitudes will be correlated with error rates in 15 
the Control group and either not correlated or less correlated in the Misattribution 16 
group. However, we also extend this further and hypothesize that there will be an 17 
indirect effect of group on error rates through the ERN/ΔERN, such that reduced 18 
ERN/ΔERN amplitudes in the Misattribution group will be related to higher error 19 
rates. 20 
4. The relationships between variables in the present replication—namely, 21 
between (1) group and the ERN/ΔERN, between (2) group and state anxiety, 22 
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and between (3) group and error rates via the ERN/ΔERN—may be 1 
moderated by trait anxiety. 2 
Unpublished work with a misattribution paradigm has suggested that the 3 
amplifying effect of trait anxiety on ERN amplitudes (e.g., Moser, Moran, 4 
Schroder, Donnellan, & Yeung, 2013) is dependent on the correct attribution of 5 
state anxiety, such that misattribution eliminates the relationship between trait 6 
anxiety and ΔERN amplitudes (Rodilla, Beauducel, & Leue, 2015). These 7 
findings highlight the importance of both state and trait anxiety in varying ERN 8 
and ΔERN amplitudes. Because both ERN/ΔERN amplitudes and state anxiety 9 
may be reduced in individuals who are low in trait anxiety (and vice-versa), 10 
relationships between variables in the present experiment may be weaker or fail 11 
to reach statistical significance when not accounting for trait anxiety. Thus, we 12 
hypothesize trait anxiety may enhance the relationships between group and the 13 
ERN/ΔERN, between group and state anxiety, and between group and error 14 
rates via the ERN/ΔERN.  15 
12
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 1 
Methods 2 
 3 
Power and Participants 4 
Prior to collecting data, we conducted an a priori power analyses in 5 
G*Power (Erdfelder, Faul, & Buchner, 1996) to determine the sample size for our 6 
study. Although the effect size of the original study was medium-to-large 7 
(η2p=.17), the original study did not have the power to accurately detect a small 8 
or medium-sized effect, and so the original effect size may be inflated (Button et 9 
al., 2013). Thus, we chose a small-to-medium effect size estimate (Cohen’s f = 10 
0.15) to accurately detect a smaller but still meaningful difference across 11 
conditions. This analysis determined that 74 participants would be needed to 12 
detect an effect of this size with 90% power using the aforementioned repeated-13 
measures ANOVA, probing for between-within interactions (see { HYPERLINK 14 
"https://osf.io/su58j/files" } for details of the power analysis). Because of our 15 
subsequent use of primarily multilevel models without random slopes in the 16 
present study, this estimated sample size provided either accurate or 17 
conservative power for all analyses (Quené & van der Bergh, 2004). 18 
Thus, prior to collecting data, we aimed to recruit 84 participants in total, 19 
expecting that some participants (10-15%) would be excluded entirely because of 20 
computer malfunction, too few usable error trials, suspicion about the effects of 21 
the placebo, or task disengagement. If after exclusions there were fewer than 19 22 
participants in any of the four counterbalanced groups (see below), recruitment 23 
would continue until there were at least 19 participants in each group. 24 
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In the beginning of recruitment, the first three participants were “pilots” 1 
used only to ensure our data collection procedures and preprocessing pipeline 2 
were free from errors. The first two of these pilot participants had computer errors 3 
that prevented complete data collection, which were fixed for the third participant. 4 
The third participant had acceptable data, so all participants after the third 5 
participant were considered valid to be included in the study. We did not 6 
preregister the use of pilot participants to ensure error-free data; however, data 7 
from these pilot participants were not analyzed, so they did not influence our 8 
hypotheses, procedures, or analyses. 9 
At the end of data collection, we recruited 82 participants in total following 10 
the third pilot participant. Based on preregistered exclusion criteria (see Data 11 
Removal Summary below), we completely excluded the data of three participants 12 
and partially excluding the data of two participants. This produced a final sample 13 
size of 79 participants for multilevel models and 77 participants for all univariate 14 
models. 15 
All participants were recruited at the University of Toronto Scarborough 16 
and received course credit or $10 payment as compensation for their 17 
involvement in the study. Advertisement for recruitment specified that participants 18 
needed to have normal or corrected-to-normal vision and must have been 19 
speaking English fluently for at least 10 years. All participants provided informed 20 
consent before participating. 21 
Procedure 22 
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Participants were told that the purpose of the experiment was to 1 
investigate the effects of an herbal supplement (called panax senticosus) on 2 
brain responses during a self-control task. However, they were only ever 3 
administered a placebo pill that contained sucrose. A specific protocol was used 4 
to increase the plausibility of this herbal supplement cover story to participants, 5 
the details of which are outlined below and described in full detail on OSF (see 6 
Cover Story Procedures at { HYPERLINK "https://osf.io/su58j/files" }). Participants 7 
were randomly assigned to one of two supplement groups (Misattribution or 8 
Control), and one of two counterbalanced ingestion groups (Supplement First or 9 
Supplement Second). The supplement group was used as a between-subjects 10 
factor in later statistical analyses, while participants in the two ingestion groups 11 
were combined in all preregistered analyses. All participants contributed two 12 
separate sets of data (the within-subjects “placebo” condition) over the course of 13 
the experiment: one set in which they believed they were under the effects of the 14 
supplement (either a “Misattribution” or “Control” supplement, depending upon 15 
their randomly assigned group), and one set in which they believed they were 16 
not. In using this mixed design, we sought to increase statistical power from the 17 
original study by having participants act as their own “control” group, i.e., 18 
performing the task both with and without the placebo pill. 19 
After giving informed consent, participants were provided information 20 
about the panax senticosus supplement and its ostensible role in the experiment 21 
on the computer screen. This information is provided verbatim below, and was 22 
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only minimally altered to address the differences in protocol between the original 1 
study and the present one. These differences are denoted in square brackets: 2 
 3 
As mentioned earlier, the purpose of this study is to investigate the effects of an 4 
herbal supplement, Panax senticosus, on cognitive performance. Panax senticosus 5 
grows along the west coast of North America (from British Columbia to California). 6 
Panax senticosus contains compounds that strengthen bones (Rhodes and Schwartz, 7 
2007), and is increasingly being used in the elderly population (Black et al., 2009). It is 8 
commonly available at health food stores and is completely safe. 9 
 10 
Although Panax senticosus has been marketed widely over the past 5 years, few 11 
studies have investigated its effects on cognitive performance. The present study was 12 
designed to address this question. In a few moments, the experimenter will give you [two 13 
pills] containing Panax senticosus [and 150 ml of filtered water in a cup]. We ask that 14 
you please [take the pill and] consume the entire [cup of water]. 15 
 16 
Misattribution Group. Following these two paragraphs, participants in the 17 
Misattribution group—but not the Control group—were then told that the herbal 18 
supplement could have minor side effects: 19 
 20 
Please note that there are certain side effects associated with Panax senticosus. 21 
Studies have documented that Panax senticosus can activate the body's sympathetic 22 
nervous system, which governs arousal (Selariu et al., 2006). Past participants have 23 
reported feeling a number of side effects, including tenseness, anxiety, increased heart 24 
rate and a racing mind. From our experience, the effects of Panax senticosus begin to 25 
occur approximately [20] minutes after ingestion and last approximately [35-40] minutes 26 
16
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[thereafter]. Please do not be alarmed if you feel [any] side effects [—] they are 1 
temporary and will disappear [before] the conclusion of today’s study session. 2 
 3 
Control Group. Conversely, participants in the Control group—and not in 4 
the Misattribution group—were told that the herbal supplement is not known to 5 
have any side effects: 6 
 7 
Please note that there are no physical side effects associated with Panax 8 
senticosus. [From our experience, the effects of Panax senticosus on the brain 9 
begin to occur approximately 20 minutes after ingenstion and last approximately 10 
35-40 minutes thereafter.] 11 
 12 
Supplement First Group. After being informed about the supplements on 13 
the computer, participants in the Supplement First group were verbally reminded 14 
of whether the supplement would have side effects, and then asked to consume 15 
a pill containing the supplement. After consuming the pill, participants were again 16 
told that they had to wait 20 minutes for it to take effect, during which time they 17 
were prepared for the EEG recording. Two minutes before the waiting period 18 
ended, participants were asked to provide a small saliva sample to verify that the 19 
supplement had “begun working”. This saliva sample was mixed into a vial that 20 
appeared to participants to contain water and starch; however, it actually 21 
contained water and iodine, and a sleight-of-hand procedure was used to switch 22 
the saliva sample with one dipped in starch. Participants saw this mixture turned 23 
blue, and were then told that this indicated that the supplement had begun 24 
working. 25 
17
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Participants were then asked to complete 3 sets of questions: a 6-item 1 
version of the State Anxiety Inventory (Marteau & Becker, 1992; Spielberger, 2 
1983), 2 questions that specifically assessed state anxiety about task 3 
performance, and a modified version of the Intrinsic Motivation Inventory 4 
(McAuley, Duncan, & Tammen, 1989). The 4-point State Anxiety Inventory is a 5 
reliable measure of state anxiety (α = .82) that includes items about feeling 6 
nervous or relaxed (e.g. “I am worried”; “I feel tense”). These items were 7 
presented with two additional items that assessed state emotions about expected 8 
task performance (i.e., “I feel good about the upcoming task”; “I am anxious 9 
about how I will perform on the task”). The modified version of the Intrinsic 10 
Motivation Inventory (IMI; McAuley, Duncan, & Tammen, 1989) contained only a 11 
set of items from the Perceived Competence (α = .80) and Effort-Importance 12 
subscales. This set of questions included four adjusted items from the former 13 
subscale that assessed expectations about the upcoming task (e.g., “I think I will 14 
be pretty good at this task”; “I think I will be satisfied with my performance at the 15 
upcoming task”), and which was used to assess performance expectations. The 16 
remaining items from the Effort-Importance subscale were present only to reduce 17 
demand characteristics. Following the completion of these questions and at the 18 
20-minute mark, participants were instructed to begin the Go/No-Go task. 19 
The protocols of this task did not differ from that of the original study. In 20 
this task, participants responded using the M key on a DirectIN PCB keyboard 21 
(Empirisoft, New York, NY) in response to two stimuli on screen, the letters M 22 
and W. The presentation probability for each stimulus presented randomly was 23 
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asymmetric, giving a correspondingly asymmetric response ratio of 85:15 for M 1 
and W, respectively. Participants were required to press the M key when they 2 
saw the “go” stimulus (i.e., the letter M) and to refrain from pressing the M key 3 
when they saw the “no-go” stimulus (i.e., the letter W). Each trial began with a 4 
fixation cross (“+”) presented randomly for 300-700 ms, which was followed by 5 
either a go or no-go stimulus for 100 ms. The maximum time allowed for a 6 
response was 500 ms, while the minimum time allowed for a response was 100 7 
ms. Participants first completed a practice block of 20 trials. These trials included 8 
response feedback for errors of omission (i.e., “respond faster!”) and errors of 9 
commission (i.e., “wrong response!”) to ensure participants understood the task. 10 
Practice trials were followed by five experimental blocks without feedback, each 11 
consisting of 85 go trials and 15 no-go trials. With this task, we measured the 12 
average reaction time for correct (i.e., key presses on “go” trials) and incorrect 13 
trials (i.e., key presses on “no-go” trials), the number of errors of commission 14 
(pressing M during a no-go trial), and the number of errors of omission (not 15 
pressing M during a go trial). 16 
After completing the first Go/No-Go task, participants then immediately 17 
completed another State Anxiety Inventory with the two questions about 18 
emotions and task performance, with the latter modified to assess current 19 
emotions about previous task performance (i.e., “I feel good about how I 20 
performed”; “I am anxious about how I performed on the task”). Participants then 21 
then waited 15 minutes for the supplement to ostensibly “wear off”. During this 22 
waiting period, participants read some provided magazines. Two minutes before 23 
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the end of this second waiting period, participants again provided a saliva sample 1 
to verify that the supplement had worn off. This sample was mixed into a vial that 2 
appeared to participants to contain water and starch. Unlike before, this mixture 3 
did not turn blue, and participants were told that this indicated that the 4 
supplement had worn off. Participants were then asked to complete a third State 5 
Anxiety Inventory with the two additional questions about emotions and task 6 
performance, and a second modified IMI Scale. Following these scales, 7 
participants were then instructed to begin the second Go/No-Go task, which 8 
contained the same number of blocks and trials as the first Go/No-Go task. 9 
After the completion of the second Go/No-Go task, participants were 10 
immediately asked to complete a fourth State Anxiety Inventory with two 11 
additional questions about emotions and task performance. This scale was 12 
followed by a BIS/BAS scale (Carver & White, 1994)—our measure of trait 13 
anxiety—and a funneled debriefing procedure (Bargh & Chartrand, 2000) to 14 
ensure that participants believed the cover story. In this procedure, participants 15 
were asked to freely respond to a series of questions that gauge their beliefs and 16 
knowledge about the experiment, its procedures, and their understanding of its 17 
intentions. The questions began by asking about the experiment very broadly, 18 
and then became increasingly specific.  19 
 20 
(1) What do you believe the experiment was about?  21 
(2) Was there anything you believed the experimenters did not tell you 22 
about the experiment?  23 
(3) What effects did you think the supplement had on you?  24 
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(4) At any point in this experiment did you think the experimenters may 1 
have deceived you, and that the supplement may have been fake? If so, at what 2 
point during the experiment did you think this? 3 
 4 
Participants were then asked about their demographic characteristics, and 5 
to verify that they had been speaking English fluently for 10 years. Finally, 6 
participants were fully debriefed, compensated, and thanked for their 7 
participation in the study. 8 
Supplement Second Group. Participants randomized into the 9 
Supplement Second group engaged in identical procedures to those in the 10 
Supplement First group, but ingested the supplement after the first Go/No-Go 11 
task instead of before it. Participants began with preparations for EEG recording, 12 
and completed a State Anxiety Inventory and modified IMI before the first Go/No-13 
Go task. After the first Go/No-Go task, they immediately completed a second 14 
State Anxiety Inventory and IMI. They were then informed about the supplement 15 
and its side effects, ingested the supplement, and waited 20 minutes for it to take 16 
effect. They then completed a third State Anxiety Inventory and IMI before the 17 
second Go/No-Go task, and a fourth State Anxiety Inventory and IMI after it. 18 
Procedures thereafter were the same as the Supplement First group. 19 
Blinding Procedures and Behavioral Exclusion Criteria. For research 20 
assistants to verbally remind participants of whether or not the placebo had side 21 
effects, they were forced to be aware of the group (Misattribution group or 22 
Control group) to which a participant had been assigned. However, they were not 23 
made aware of any of the dependent variables or hypotheses of the experiment 24 
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until its completion. They were asked not to read the debriefing form over the 1 
course of data collection. In general, because most instructions and participant 2 
task performance are computer-administered, experimenter effects on participant 3 
behavior were small. 4 
Only participants who explicitly reported having believed the placebo pill 5 
was fake had their “supplement” data excluded, and only the portion of their data 6 
during the time in which they believed the placebo was fake. Participants who 7 
expressed suspicion about certain aspects of the procedures—but not 8 
specifically suspicion about the placebo—did not have their data excluded. 9 
Participants who only expressed some level of suspicion about the placebo did 10 
not have their data excluded. Participants in the Misattribution group who 11 
reported believing that the placebo had no effect on them also did not have their 12 
data excluded; unregistered, exploratory analyses excluding these participants 13 
did not change any of our results. 14 
Participants had their data excluded if they had an overall commission or 15 
omission error rate greater than 45% for all trials, collapsed over placebo 16 
condition. Further, even if a participant verbally reported understanding the 17 
directions and had been speaking English for more than 10 years, they would 18 
have had their data excluded if there was substantial evidence that they were no 19 
longer following directions or had disengaged from the task. Evidence that 20 
participants had disengaged from the task included pressing the response key 21 
without looking at the screen, which experimenters checked for by observing 22 
participants surreptitiously on each block of trials. 23 
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Neurophysiological Recordings and Artifact Removal. Continuous 1 
EEG activity was measured over the cortical midline (Fz, FCz, Cz, CPz, Pz, Oz) 2 
using 6 Ag/AgCL electrodes embedded in a stretch Lycra cap (Electro-Cap 3 
International, Eaton, OH). Vertical electrooculography (VEOG) was recorded 4 
using a supra-to-suborbital bipolar montage placed around the right eye. EEG 5 
activity was amplified using an ANT Refa8 TMSi (Advanced Neuro Technoloy, 6 
Enschede, The Netherlands) device. The continuous EEG signal was grounded 7 
to the forehead and referenced online to the average of all electrodes. Offline, 8 
the EEG signal was re-referenced to the average of two bilaterally placed ear 9 
lobe electrodes. Impedances were kept below 5 kΩ for all recordings. Recordings 10 
were digitized at 512 Hz using Advanced Source Analysis 4.9.2 software.  11 
All filtering, artifact corrections, and segmentation of EEG data were then 12 
implemented in BrainVision Analyzer 2.0 (Brain Products GmbH, Gilching, 13 
Germany). EEG data were digitally filtered between 0.1 and 20 Hz (24 dB/oct, 14 
zero phase-shift Butterworth filter), and corrected for blink artifacts using an 15 
independent components analysis procedure (Makeig, Bell, Jung, & Sejnowski, 16 
1996). Automatic procedures were then used to reject EEG artifacts from 17 
individual channels according to the following criteria: voltage steps of more than 18 
25 μV between sample points, a voltage difference of 150 μV within 150-ms 19 
intervals, voltages above 100 μV and below -100 μV, and a maximum voltage 20 
difference of less than 0.50 μV within 100-m intervals. Participants with more 21 
than 35% of their EEG epochs rejected this way within placebo condition or trial 22 
type—regardless of whether they have enough artifact free trials remaining to 23 
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reach a dependability threshold (described below)—had their data excluded from 1 
analyses involving ERP data. 2 
Participants had averaged cells of their data excluded if they did not have 3 
at least 6 artifact-free trials within them for an internally reliable signal. Previous 4 
research suggests that ERN amplitudes becomes moderately reliable (α > .50) in 5 
6 trials in undergraduates (Meyer, Riesel, & Proudfit, 2013; Olvet & Hajcak, 6 
2009).  7 
As reliability is dependent on each specific sample and condition of any 8 
experiment, dependability estimates (a generalizability theory [G-theory] 9 
analogue of reliability) were also calculated for each supplement group, placebo 10 
condition, and trial type using the ERP Reliability Analysis Toolbox (Clayson & 11 
Miller, 2017a; 2017b). This toolbox calculates ERP reliability based on algorithms 12 
from generalizability theory (see Baldwin, Larson, & Clayson, 2015 for review) 13 
and used CmdStan v2.17.1 (Stan Development Team, 2016) to implement the 14 
analyses in Stan (Carpenter et al., in press). Overall dependability estimates and 15 
their 95% credible intervals (CIs) for cell averages used the mean number of 16 
trials retained for each supplement group, placebo condition, and trial type. 17 
Participants whose data would have been excluded only because of too 18 
few trials remaining after artifact-removal had their missing data estimated using 19 
multilevel models (see Analysis Procedures and below). Conversely, participants 20 
who did not have enough artifact-free trials because of naturally low error rates 21 
would not have had their data estimated this way, and would have been removed 22 
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from analyses entirely. However, no participants were excluded either for having 1 
too few trials after artifact-removal or for having naturally low error rates.  2 
Epochs were defined as between 200 ms before and 800 ms after the 3 
response, and baseline corrected using a -150 to -50 ms pre-response window. 4 
For statistical analyses, the ΔERN was operationalized using a collapsed 5 
localizer method (cf., Luck & Gaspelin, 2017). In this method, we collapsed data 6 
across all groups and conditions to determine the time window and scalp 7 
distribution that best characterized the ΔERN. The mean amplitude measure 8 
taken from the chosen electrode was then used to analyze the non-collapsed 9 
data for the all hypothesis tests. The same time window and electrode site 10 
determined for the ΔERN was also used to operationalize the ERN and its 11 
correct-trial counterpart (the correct-response negativity; CRN). Using the 12 
collapsed localizer method, we operationalized our ERPs with a time-window of 13 
15 ms pre-response to 115 ms post-response over the FCz electrode. 14 
Data Removal Summary. Participant exclusions and recruitment, artifact 15 
removal, and data organization for statistical tests occurred in the following 16 
ordered steps: 17 
1. Participants or portions of participant data were excluded based on 18 
belief that the placebo was fake, too high error rates, and evidence for 19 
task disengagement. If this procedure had reduced the number of 20 
participants in a counterbalanced group below 19, recruitment and 21 
exclusion would have continued until there were at least 19 22 
participants in each group. Using this procedure, one participant was 23 
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removed for belief that the placebo was fake, and two participants 1 
were removed for too high omission error rates. 2 
2. Individual trial epochs for remaining participants were removed based 3 
on artifact rejection criteria. 4 
3. Portions of participant ERP data were excluded for having more than 5 
35% of all EEG epochs removed from that placebo condition and trial 6 
type. Using this procedure, two participants had half of their ERP data 7 
removed. 8 
4. Portions of participant ERP data were excluded for having less than 6 9 
artifact-free trials within a cell average. No data were removed using 10 
this procedure. 11 
5. For multilevel models, participants with missing data for a given cell 12 
were excluded entirely from analyses that require full data, unless data 13 
was missing exclusively because of artifact rejection or computer 14 
errors (Step 3). No participants were excluded from analyses this way. 15 
Participants with missing cell average trial numbers that would have 16 
been 6 or greater (Step 4) had they not been rejected due to artifacts 17 
(Step 3) were included in all multilevel models. 18 
Missing Data. Because of a computer error, all state self-report data for 19 
the first 32 participants had to be recovered manually from recorded key presses 20 
in our physiological data. Because we did not always begin recording 21 
physiological data immediately when participants started responding to self-22 
reports, 16 participants had missing data for at least one of four measurement 23 
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times of three possible variables: state anxiety, task-specific anxiety, or 1 
performance expectations. Of all measurement points for all three of these 2 
variables, only 5.2% of data in total was missing. Because no participants had 3 
entirely missing data for all measurement points of any variable, all missing data 4 
were capable of estimation using multilevel models. Because our missing data 5 
qualified as Missing Completely At Random (Little & Rubin, 2002), these models 6 
provided unbiased estimates of missing data. 7 
 Analysis Procedures 8 
To account for heteroskedastic, non-spherical, and excluded data (Quené 9 
& van der Bergh, 2004), multilevel models were calculated in SPSS (v23) for 10 
almost all analyses. Because tests of the relationship between ERP amplitudes 11 
and error rates did not contain any within-subjects factors, we decided before 12 
analyzing data that they would be calculated using univariate analyses of 13 
variance (ANOVAs). All analyses were conducted in SPSS using the MIXED or 14 
UNIANOVA functions, and all main and interaction effects were evaluated using 15 
a Type III sums of squares approach. 16 
For the multilevel models, we used a restriction maximum likelihood 17 
method for fitting, and an unstructured covariance matrix and Satterthwaite 18 
method to estimate random intercepts for each participant for all fixed effects. For 19 
ANOVAs, we decided before analyzing data that if residuals were found to be 20 
non-Normal based on significant results from Shapiro-Wilk or Kolmogorov-21 
Smirnov tests, we would log-transform or natural-log transform dependent 22 
variables (i.e., commission error rates) until these tests were nonsignificant. The 23 
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residuals for all tested models were found to be sufficiently Normal (all ps > .20), 1 
so error rates were not subsequently transformed. 2 
 For statistical calculations, effect sizes are denoted using either 3 
semipartial R2 (R2β; Edwards, Muller, Wolfinger, Qaqish, & Schabenberger, 2008) 4 
or partial η2 (ηp2; Cohen, 1973). To reduce the incidence of Type I error from 5 
multiple comparisons, tests for different dependent variables were corrected 6 
using a false discovery rate procedure (Benjamini & Hochberg, 1995; Benjamini 7 
& Yekutieli, 2001). 8 
Statistical Tests & Results 9 
Statistical tests divided by category are described below, followed by their 10 
results. Interaction terms are denoted using an asterisk (*) between factors. Our 11 
models assessed the effect of group (misattribution vs. control), placebo 12 
condition (on vs. off the placebo), trial type (error vs. correct trials), and time 13 
(before vs. after the task) on our behavioral, physiological, and self-report 14 
measures. In our multilevel models, these categorical variables were effect 15 
coded such that data from the misattribution group were = 1, while data from the 16 
control group were = -1; data under the effects of a placebo were = 1, while data 17 
not under the effects of a placebo were = -1; data from error trials were = 1, while 18 
data from correct trials were = -1, and data from before the task were = -1, while 19 
data from after the task were = 1. 20 
For all tests, only interactions with p-values below 0.05 were followed up 21 
by simple effect or simple slope analyses, and only significant p-values of interest 22 
were corrected using a false discovery rate procedure for all tests within the 23 
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same dependent variable (so if a main effect is significant but is not of direct 1 
interest to our hypotheses, its p-value would not be included in a correction 2 
procedure). Please note that all models conducted with trait anxiety and all post-3 
hoc analyses were exploratory, and may be underpowered. 4 
The CRN, ERN, and ΔERN 5 
One multilevel model was calculated to assess CRN and ERN amplitude 6 
across groups, placebo condition, and trial type, and another calculated to 7 
assess ΔERN amplitude across groups and condition. For the first model, the 8 
between-subjects factor of group (Misattribution and Control), within-subjects 9 
factor of placebo condition (Placebo and Non-Placebo), within-subjects factor of 10 
trial type (Correct and Error), and three-way group*condition*trial type interaction 11 
term were used to predict ERN amplitudes. These predictors were also 12 
accompanied by all other possible two-way interactions between factors that 13 
were not of central interest to our hypotheses. For the second model, the same 14 
predictors without a trial type factor—and with a group*condition interaction term 15 
instead of the three-way interaction term—were used to predict ΔERN amplitude. 16 
 For the ERN, we hypothesized that there would be a significant three-way 17 
interaction between group, placebo condition, and trial type. A simple effects 18 
analysis of this interaction would reveal that ERP amplitudes would be smaller 19 
(i.e., less negative) in the Misattribution group than in the Control group, 20 
specifically for Placebo data and for error trials. For the ΔERN, we hypothesized 21 
that there would be a significant two-way interaction between group and 22 
condition, and that a simple effects analysis of this interaction would reveal that 23 
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ERP amplitudes would be smaller in the Misattribution group than in the Control 1 
group, specifically for Placebo data. 2 
 3 
Figure 1. Error- and correct-related ERP amplitudes over the frontocentral electrode (FCz) 4 
across placebo condition and supplement group. The ERN, CRN, and ΔERN were 5 
operationalized in all statistical tests as the mean activity between 15 and 115 ms. 6 
 7 
Results. Overall dependability estimates and trial characteristics of the 8 
CRN and ERN are depicted in Tables 1 and 2. 9 
Indicating the presence of a robust ERN, error trials had more negative 10 
amplitudes (M = -4.69, SE = 0.49) compared to correct trials (M = 5.53, SE = 11 
0.49), b = 11.81, SE = 0.96, F(1,227.808) = 454.053, p < .001, R2β = 0.67 (see 12 
Figure 1). For both the ERN and ΔERN, there were no significant main effects of 13 
group, Fs < 1.986, ps > .163, nor of condition, Fs < 1.480, ps > .228. Contrary to 14 
our predictions, we did not observe a significant three-way interaction between 15 
trial type, group, and condition for the ERN, F = 0.341, p = .560, nor a significant 16 
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two-way interaction between group and condition for the ΔERN, F = 1.230, p = 1 
.271. These findings suggest that ERP amplitudes were not influenced by the 2 
type of placebo participants consumed, nor by whether participants were on or 3 
off the placebo. 4 
Exploratory Analyses. The null findings for ERP amplitude may have 5 
been confounded by order, such that participants’ emotions could have been 6 
altered when they performed the Go/No-Go task for the second time. To account 7 
for these effects, we conducted the same multilevel analysis on ERN amplitudes 8 
as specified above, but only included Placebo data for participants who 9 
consumed the placebo the first time they performed the task. For the ΔERN, we 10 
similarly conducted a one-way ANOVA for the effect of group on ERP 11 
amplitudes. These two analyses can be considered conceptually equivalent to 12 
the between-subjects tests conducted by Inzlicht & Al-Khindi (2012), with n = 19 13 
for both Misattribution and Control groups. It should be noted that these analyses 14 
are underpowered, and so results should be interpreted with caution. 15 
Like our standard analyses, we found a significant effect of trial type on 16 
ERP amplitudes, F(1,36) = 116.198, p < .001, R2β = 0.76, but no significant main 17 
effects of group or significant interactions between trial type and group for the 18 
ΔERN or ERN, respectively, Fs < 0.734, ps > .397. These findings suggest that 19 
even after eliminating potential order effects, ERP amplitudes were not 20 
influenced by the type of placebo participants consumed. 21 
Table 1 22 
Estimates of dependability and 95% credible intervals of error- and correct-related ERP 23 
amplitudes across groups and placebo condition 24  Control   Misattribution 
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 Off Placebo   On Placebo   Off Placebo   On Placebo 
ERN Est LB UB   Est LB UB   Est LB UB   Est LB UB 
OD 0.85 0.77 0.91 0.90 0.85 0.94 0.88 0.82 0.93 0.92 0.88 0.95 
BSSD 4.95 3.69 6.54 6.35 4.86 8.16 5.52 4.31 7.12 7.06 5.41 9.22 
WSSD 11.82 11.35 12.32 11.93 11.46 12.40 11.37 10.93 11.82 11.89 11.45 12.36 
ICC 0.15 0.09 0.24 0.22 0.14 0.32 0.19 0.12 0.28 0.26 0.17 0.38 
CRN                   
OD 0.98 0.98 0.99 0.98 0.97 0.99 0.99 0.98 0.99 0.99 0.99 1.00 
BSSD 4.28 3.39 5.48 3.79 3.05 4.78 4.96 3.97 6.23 6.56 5.23 8.30 
WSSD 10.27 10.16 10.39 10.50 10.38 10.61 10.32 10.20 10.43 10.77 10.65 10.89 
ICC 0.15 0.10 0.22 0.12 0.08 0.17 0.19 0.13 0.27 0.27 0.19 0.37                            1 
Note. ERN = error-related negativity; CRN = correct-related negativity; Est = point estimate; LB = 2 
lower-bound; UB = upper-bound; OD = overall dependability; BSSD = between-subjects standard 3 
deviation; WSSD = within-subjects standard deviation; ICC = Intra-class correlation. 4 
 5 
Table 2 6 
Trial characteristics of ERP amplitude data submitted to dependability analyses across 7 
groups and placebo condition. 8  9  Control   Misattribution  Off Placebo   On Placebo   Off Placebo   On Placebo  ERN CRN   ERN CRN   ERN CRN   ERN CRN 
Mean # Trials 34.47 388.00 33.33 386.74 32.00 387.28 34.10 385.98 
Min # Trials 19 316 9 272 11 129 11 37 
Max # Trials 58 423 60 425 65 424 63 422 
Trial Cutoff 14 14 9 13 11 11 7 9 
N Included 38 39 39 39 39 40 39 40 
N Excluded 1 0 0 0 1 0 0 0                            10 
Note. ERN = error-related negativity; CRN = correct-related negativity. Trial Cutoff refers to the 11 
minimum number of trials necessary to reach dependability of 0.70; results of present study 12 
remained unchanged when participants with data beneath the minimum cutoff were excluded. 13 
 14 
State and Task-Related Anxiety 15 
Two multilevel models were calculated to assess state and task-related 16 
anxiety across groups and time, looking only at data within the Placebo condition. 17 
For both models, state and task-related anxiety were predicted by group 18 
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(Misattribution and Control), time (Pre-task and Post-task), and a group*time 1 
interaction term. 2 
We hypothesized that there would be significant interactions between 3 
group and time for both measures of anxiety. Simple effects analyses of these 4 
interactions would reveal that state and task-related anxiety would rise from pre-5 
task to post-task more for the Control group than for the Misattribution group. 6 
  7 
Figure 2a & 2b. State and task-related anxiety across time and group while participants were on 8 
the placebo. Error bars denote 95% between-subjects confidence intervals. Scale responses 9 
ranged from 1 to 4. 10 
 11 
Results. When participants were on the placebo, state anxiety increased 12 
significantly from before the task (M = 1.80, SE = 0.07) to after the task (M = 13 
2.07, SE = 0.06), b = -0.27, SE = 0.09, F(1,66.736) = 17.947, p < .001, R2β = .21, 14 
indicating that our task induced a mild increase in state anxiety (see Figure 2a). 15 
This increase was also true of task-related anxiety from before the task (M = 16 
1.99, SE = 0.08) to after the task (M = 2.51, SE = 0.07), F(1,71.543) = 32.355, p 17 
< .001, R2β = .31 (see Figure 2b). These findings replicate those of our original 18 
study. There were no significant effects of group on state or task-related anxiety, 19 
Fs < 0.781, ps > .380. 20 
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Contrary to our main predictions, there were no significant two-way 1 
interactions between group and time, Fs < .510, ps > .478. These findings 2 
indicate a crucial manipulation failure: the misattribution placebo did not influence 3 
the increase in state anxiety from pre- to post-task compared to the control 4 
placebo. Because our manipulation did not influence affect, our data cannot test 5 
the theory that the ERN has emotional properties. 6 
Exploratory Analyses. Because state anxiety was low in general for the 7 
present study, misattribution may have only occurred in participants who 8 
experienced a larger rise in state or task-related anxiety when not on the 9 
placebo. We performed two additional multilevel models for the ΔERN to see 10 
whether the interaction between group and condition was moderated by the 11 
difference in state and task-related anxiety from before to after the task. In these 12 
models, ΔERN amplitudes were predicted by group, placebo condition, the 13 
difference in anxiety from before the task to after the task while off the placebo, 14 
and all two- and three-way interactions for these predictors. In both models, no 15 
predictors were significantly related to the ΔERN, all Fs < 2.553, all ps > .117. 16 
These findings show that changes in anxiety when off the placebo were 17 
altogether unrelated to the effects of group and condition on ERP amplitudes. 18 
Behavior and Performance Expectations 19 
Five multilevel models were calculated to assess the similarity in 20 
behavioral performance and performance expectations across groups and 21 
placebo condition. For all five models, each of the following dependent variables 22 
were predicted by group and placebo condition: commission error rates, omission 23 
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error rates, correct-trial reaction times, error-trial reaction times, and self-reported 1 
performance expectations. We hypothesized that there will be no significant 2 
interaction between group and placebo condition for all five tests, so that we 3 
would fail to reject the null hypothesis that there was a significant difference in 4 
behavioral performance and performance expectations across conditions and 5 
within groups. 6 
Results. We found no significant effects of group, condition, or their 7 
interaction for any of our five measures, all Fs < 3.908, all ps > .052 (see Table 8 
2). Because our first test on performance expectations combined data from 9 
before and after the task, we conducted a second test of performance 10 
expectations to distinguish these sets of data. In this model, performance 11 
expectations were predicted by time, group, condition, their three-way interaction, 12 
and all two-way interactions not of interest to our hypotheses. We found a 13 
significant effect of time, b = 0.46, SE = 0.10, F(1, 76) = 119.564, p < .001, R2β = 14 
.61, such that participants rated their performance expectations before the task 15 
more positively (M = 2.67, SE = 0.06) than after the task (M = 2.12, SE = 0.06). 16 
There were no significant effects of group, condition, or the three-way interaction 17 
between group, condition, and time on performance expectations, all Fs < 1.335, 18 
all ps > 0.249. These findings show that regardless of group or placebo condition, 19 
participants’ performance expectations dropped over time, reflecting a tendency 20 
among participants to overestimate their competence before performing the task. 21 
In line with our predictions, these findings show that our misattribution 22 
paradigm did not significantly influence behavior or performance expectations 23 
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from before to after the task, either as a function of the type of placebo 1 
consumed or as a function of being on or off the placebo. 2 
Table 3 3 
Means and 95% between-subjects confidence intervals of behavior, performance 4 
expectations, and ERP amplitudes across groups and condition. 5  6  Control (n = 39)   Misattribution (n = 40)  Off Placebo   On Placebo   Off Placebo   On Placebo  Mean LB UB   Mean LB UB   Mean LB UB   Mean LB UB 
Om ER (%) 5.48 3.60 7.35 5.20 3.46 6.94 5.05 2.94 7.16 4.19 2.79 5.60 
Com ER (%) 46.67 42.15 51.28 45.73 40.72 50.74 42.68 37.05 48.32 46.80 41.07 52.53 
RT Correct 292 285 299 293 283 302 294 282 306 289 276 302 
RT Error 250 244 256 246 239 254 247 240 255 246 238 354 
Pre-task PE 2.71 2.51 2.91 2.73 2.55 2.90 2.60 2.38 2.81 2.64 2.39 2.89 
Post-task PE 2.05 1.83 2.28 2.13 1.96 2.29 2.08 1.85 2.30 2.18 1.97 2.38 
ERN -4.24 -5.92 -2.57 -3.94 -6.07 -1.80 -4.78 -6.58 -2.98 -5.68 -7.88 -3.48 
ΔERN -9.62 -11.50 -7.74 -9.67 -11.89 -7.44 -11.09 -13.06 -9.13 -12.21 -14.43 -10.00                            7 
Note. LB = uower-bound; UB = upper-bound; Om ER = omission error rates; Com ER = 8 
commission error rates; PE = performance expectations. RTs are denoted in milliseconds and 9 
ERP amplitudes are denoted in microvolts. 10 
 11 
The Brain and Behavior Relationship 12 
Two ANOVAs were used to assess the relationship between ERP 13 
amplitudes and commission error rates as a function of group: one for the ERN, 14 
and another for the ΔERN. These tests were conducted only on Placebo data. 15 
For both models, error rates were predicted by ERP amplitude, group, and an 16 
amplitude*group interaction term. For both the ERN and ΔERN, we hypothesized 17 
that there would be significant interactions between ERP amplitude and group. 18 
Simple slopes analyses of these interactions would reveal that ERP amplitudes 19 
on error trials would be negatively correlated with error rates, but only for the 20 
Control group and not the Misattribution group (or at least more for the Control 21 
group than for the Misattribution group).  22 
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We also hypothesized that ERP amplitudes would mediate the relationship 1 
between group and commission error rates in Placebo data, such that reduced 2 
ERN/ΔERN amplitudes in the Misattribution group would be related to increased 3 
error rates. In conducting these mediation models, we assumed there would be a 4 
significant effect of group on ERP amplitudes; however, because group was not 5 
significantly related to ERP amplitudes in earlier tests, we did not conduct these 6 
models. 7 
 8 
Figure 3a & 3b. Correlations between ERP amplitudes and commission error rates as a function 9 
of group. 10 
 11 
Results. When participants were on the placebo, we found significant 12 
main effects of ERN amplitudes on commission error rates, b = 0.01, SE < 0.01, 13 
F(1, 39) = 18.807, p < .001,  = .20, such that ERN amplitudes became larger 14 
(i.e., more negative) as error rates decreased (see Figure 3a). This same main 15 
effect was also found for ΔERN amplitudes in the same direction, b = 0.01, SE < 16 
0.01, F(1, 39) = 7.986, p = 0.006,  = .10 (see Figure 3b). However, there were 17 
no significant main effects of group nor significant two-way interactions between 18 
ERP amplitudes and group on error rates, all Fs < 1, ps > .381. Contrary to our 19 
predictions, we did not observe a reduction in the correlation between ERP 20 
2
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amplitudes and error rates for participants under the effects of the misattribution 1 
placebo compared to those under the effects of the control placebo. These 2 
findings show that the misattribution paradigm failed to disentangle the 3 
relationship between brain and behavior, unlike our original study. 4 
Trait Anxiety 5 
 Each preregistered analysis above was accompanied by a model that 6 
included an additional main effect of trait anxiety, and all possible two-, three-, or 7 
four-way interactions between trait anxiety and other predictors. These models—8 
preregistered but exploratory—assessed whether any principal interactions of 9 
interest were moderated by trait anxiety, such that trait anxiety would confound 10 
significant interactions or suppress non-significant ones. 11 
Results. Trait anxiety did not moderate any of our interactions of interest, 12 
all Fs < 1.402, all ps > .206. It also did not have a significant main effect on ERP 13 
amplitudes or state anxiety, Fs < 1.609, ps > .209, failing to replicate positive 14 
correlations found in previous studies (see Moser et al., 2013; Weinberg et al., 15 
2012). Trait anxiety did not suppress the effect of misattribution on ERP 16 
amplitudes, state anxiety, or the relationship between brain and behavior, nor did 17 
it confound significant increases in state anxiety from before to after the task.  18 
However, trait anxiety was positively correlated with task-related anxiety, b 19 
= 0.07, SE = 0.02, F(1, 69.171) = 10.120, p = .002, R2β = .13, showing that while 20 
anxious participants did not report greater anxiety in general, they did report 21 
greater anxiety about their task performance. 22 
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In tests of the relationship between ERP amplitudes and error rates, trait 1 
anxiety was also positively correlated with commission error rates for the model 2 
involving the ERN, b = 0.01, SE = 0.01, F(1, 39) = 4.275, p = 0.042,  = 0.06, 3 
but not the model involving the ΔERN, F = 3.482, p = 0.066. This effect did not 4 
survive a correction for multiple comparisons, padjusted = 0.082. To clarify these 5 
findings, we recalculated the tests without ERP amplitude as a predictor, finding 6 
that trait anxiety was positively correlated with commission error rates, b = 0.01, 7 
SE = 0.01, F(1, 39) = 8.483, p = 0.005,  = 0.10. These findings show that 8 
relationship between trait anxiety and error rates disappears when accounting for 9 
ERP amplitudes. 10 
Discussion 11 
We reproduced a previous study of ours (Inzlicht & Al-Khindi, 2012) that 12 
had revealed the emotional properties of the ERN by manipulating emotions 13 
through a misattribution of arousal paradigm. In this previous study, 14 
misattribution of arousal reduced ERN amplitudes and state anxiety without 15 
concurrently altering behavior or performance expectations. The study also found 16 
that misattribution reduced the negative correlation between ERN amplitudes and 17 
error rates. These findings showed that the ERN could be dissociated from 18 
performance, but not from negative affect. While other studies have described 19 
the emotional properties of the ERN, this was one of the first to do so while 20 
experimentally controlling for task-related behavior and performance 21 
expectations. 22 
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In the present study, we modified the design and analyses of the original 1 
study to increase statistical power, but subsequently failed to replicate its three 2 
principal findings. Although our paradigm did not alter behavior or performance 3 
expectations as expected, it also did not reduce state anxiety, the amplitude of 4 
the ERN/ΔERN, or the negative correlation between ERP amplitudes and error 5 
rates. Further, trait anxiety did not significantly moderate any of the interactions 6 
between these measured variables, and our results were unchanged when order 7 
effects and changes in state anxiety were controlled for in exploratory analyses. 8 
It is unclear why our paradigm failed to reduce state anxiety or ERN 9 
amplitudes. Although participants believed in the effects of the placebo, we did 10 
not ask them about the degree to which they may have misattributed their 11 
emotions to it. Participants who did not report the placebo having a strong effect 12 
may have felt that it was too mild to impact their anxiety. Conversely, participants 13 
who believed the placebo had a strong effect on them may have viewed it as a 14 
threat to their performance, and thus enhanced their own levels of performance-15 
monitoring to compensate for errors “caused by” the placebo. Given the range of 16 
participants’ possible responses to our paradigm, the present study may have 17 
benefited from collecting and coding participants’ construals of the placebo in 18 
greater detail. 19 
Because the present study failed to manipulate state anxiety through 20 
misattribution, our data cannot address the question of the ERN’s emotional 21 
properties. Our measure of state anxiety served as a manipulation check for 22 
misattribution, where we expected the rise in anxiety from pre-to-post task to be 23 
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blunted for participants taking the misattribution placebo compared to those 1 
taking the control placebo. Our data failed this manipulation check, with changes 2 
in anxiety being the same across groups. Because of this manipulation failure, 3 
our study cannot provide evidence for or against the hypothesis that the ERN has 4 
emotional properties. 5 
Despite these findings, the present study still contributes important 6 
information toward research on emotions, misattribution, and the ERN. In the 7 
following sections, we will interpret the present findings in the context of the two 8 
previous related studies and discuss future research in this area. 9 
The Present Study in Context 10 
The failure of our paradigm to manipulate emotions aligns with the findings 11 
of Rodilla et al. (2016), the only other published replication attempt of Inzlicht and 12 
Al-Khindi (2012). Using a high-powered version of the original study, the authors’ 13 
misattribution paradigm failed to reduce state anxiety and ERN amplitudes, and 14 
they did not find evidence for or against replication of the correlation between 15 
ΔERN amplitudes and error rates. This failure to replicate may have occurred 16 
because of unreported differences in methodology between the two studies, 17 
which could have influenced the paradigm or participants’ behavior. For example, 18 
for reasons that are unclear, reaction times in the replication attempt were faster 19 
than those in the original study. However, equality-of-effect Bayes factors 20 
(Bayarri & Mayoral, 2002) indicated that the mean differences in behavioral 21 
variables across groups within each study were comparable, such that each 22 
study’s misattribution paradigm exerted equivalent nonsignificant effects on error 23 
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rates and reaction times. This showed that despite methodological differences 1 
between the studies, their respective misattribution paradigms were at least 2 
equivalent in their influence on behavior. 3 
When considered together, the present study and replication attempt cast 4 
doubt on the replicability of the original study. This is for three major reasons. 5 
The first reason is the fundamental similarities between the present study and 6 
original study. Except for alterations made to increase statistical power, the 7 
materials and sampling populations of the two studies were nearly identical (e.g., 8 
same written directions, same laboratory environment, same recruiting 9 
procedures, etc.). 95% between-subject confidence intervals across the two 10 
studies overlapped for all measures except the ERN and ΔERN (see Table 4). 11 
Results from the present study were also unchanged when split to eliminate 12 
order effects and replicate the precise tests of the original study. Thus, it is 13 
unlikely that the different findings across the two studies can be attributed to 14 
differences in methodology. 15 
Table 4 16 
Means and 95% between-subject confidence intervals of behavior, performance 17 
expectations, and ERP amplitudes across studies for On Placebo data. 18  19  Present Study   Inzlicht & Al-Khindi (2012)  Control   Misattribution   Control   Misattribution  Mean LB UB   Mean 
 
LB UB   Mean LB UB   Mean LB UB 
Om ER (%) 5.20 3.46 6.94 4.19 2.79 5.60 3.83 2.28 5.38 4.89 2.69 7.09 
Com ER (%) 45.73 40.72 50.74 46.80 41.07 52.53 47.01 39.84 54.17 47.79 41.06 54.52 
RT Correct 293 283 302 289 276 302 288 278 297 283 266 258 
RT Error 246 239 254 246 238 354 245 238 253 245 232 258 
Pre-task PE 2.73 2.55 2.90 2.64 2.39 2.89 2.67a 1.84 a 3.50 a 3.12a 2.11 a 4.13 a 
Post-task PE 2.13 1.96 2.29 2.18 1.97 2.38 n/a n/a n/a n/a n/a n/a 
ERN -3.94 -6.07 -1.80 -5.68 -7.88 -3.48 -6.52 -8.40 -4.64 -3.92 -4.90 -2.94 
ΔERN -9.67 -11.89 -7.44 -12.21 -14.43 -10.00 -4.25 -6.86 -1.64 -1.87 -3.36 -0.38              
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              1 
Note. LB = lower-bound; UB = upper-bound; Om ER = omission error rates; Com ER = 2 
commission error rates; PE = performance expectations. Subscripts denote data from pilot study. 3 
This table only depicts data while participants were under the effects of the placebo. 4 
 5 
The second reason is that both the present study and the replication 6 
attempt had high power, while the tests of the original study had medium or low 7 
power. If we assume that we accurately determined the true effect size of 8 
misattribution on ERN amplitude (  = 0.17) in the original study, we had only a 9 
75% chance of successfully capturing that effect (i.e., 75% power). Conversely, 10 
both the replication attempt and present study had a priori power of 98% or 11 
greater to detect an effect of this same size. Further, if the small-to-medium 12 
effect size calculated for the present study had been the true effect size (about  13 
= 0.02), our original study would have had only a 14% chance of capturing it (i.e., 14 
14% power). This was also true for the power of the original study’s manipulation 15 
check; with a sample size of 47 in the pilot study, the test for the difference in 16 
state anxiety across groups had only a 61% chance of capturing its acquired 17 
medium-to-large effect (d = .66) and would have had only a 17% chance of 18 
capturing that effect had its true size been small-to-medium (d = .35). 19 
The third reason is that the present study was fully preregistered, while 20 
our original study was not. Because all primary analyses and exclusion criteria 21 
were determined before data collection took place, the present study had few 22 
experimenter degrees of freedom that could have inflated the rate of false 23 
positives. In contrast, our original study had undisclosed flexibility in statistical 24 
analyses, exclusion criteria, and the content of hypotheses, increasing the 25 
chance that at least some of those positive findings were false. Indeed, several 26 
2
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procedures in the original study lacked details or explicit justification, giving us 1 
the opportunity to inadvertently adjust data in support of our hypotheses. For 2 
example, we did not justify log-transforming commission error rates before 3 
correlating them with ΔERN amplitudes, and did not perform this same 4 
transformation for error rates when they were compared across groups. 5 
Inconsistent transformation procedures without explicit justification are not 6 
evidence of p-hacking, but do reveal the analytic flexibility that was available to 7 
us in our statistical procedures at the time. 8 
 Two high-powered replication attempts with failed manipulation checks are 9 
reasonable grounds to question the validity of the paradigm used in the original 10 
study. However, these findings should not be misinterpreted as providing 11 
evidence that misattribution cannot reduce the amplitude of the ERN, nor that a 12 
successful manipulation of the ERN requires a substantially different approach to 13 
misattribution than the approach employed in the original study. Until a 14 
misattribution paradigm is developed that passes manipulation checks with 15 
greater reliability, researchers should treat Inzlicht & Al-Khindi (2012) with more 16 
caution as experimental evidence for the emotional properties of the ERN. 17 
The Future of Misattribution and the ERN 18 
Our findings should also not be interpreted as evidence against the idea 19 
that the ERN has emotional properties, nor as evidence against the efficacy of 20 
misattribution of arousal paradigms in general. There are many independent lines 21 
of experimental and non-experimental evidence expounding on the role of affect 22 
in error monitoring (e.g., Koban & Pourtois, 2014; Saunders, Lin, Milyavskaya, & 23 
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Inzlicht, 2017; Weinberg et al., 2012), and misattribution paradigms have shown 1 
promise in other areas of psychology (e.g., Heerdink, van Kleef, Homan, & 2 
Fischer, 2015; Huang & Gong, 2018; Yeung, Sharpe, Glozier, Hackett, & 3 
Colagiuri, 2017). 4 
Instead, our findings should highlight the critical role of preregistered 5 
replications in creating a comprehensive and reproducible literature on a topic. 6 
Many studies conducted prior to the replication crisis (see Pashler & 7 
Wagnemakers, 2012) are underpowered, only a small proportion of studies in 8 
psychology have received published direct replications, and no published study 9 
in experimental psychology was preregistered before 2013. Indeed, these facts 10 
all pertain to the five most-cited publications that use a misattribution of arousal 11 
procedure (Cantor, Zillman & Bryant; 1975; Payne, Cheng, Govorun, & Stewart, 12 
2005; Schwarz & Clore, 1983; Storms & Nisbett, 1970; Zanna & Cooper, 1974), 13 
which across eleven studies have a mean of only 18.58 (SD = 4.69) participants 14 
per cell2. The present study adds nuance to this literature, remedying potential 15 
publication bias and drawing attention to findings that may require greater 16 
scrutiny. 17 
The present study should also serve as a model for studies investigating 18 
the emotional properties of error monitoring signals that have yet to receive 19 
published replications. This is particularly the case for experimental studies that 20 
control for the cognitive and behavioral aspects of error monitoring. For example, 21 
Spunt and colleagues (2012) found that error-related activity in the dorsal medial 22 
                                                             2 As assessed on Web of Science and Google Scholar, June 2018. 
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frontal cortex tracked subjective reports of frustration; these findings held after 1 
controlling for cognitive engagement and task performance. Pfabigan et al. 2 
(2013) found that experimentally induced helplessness enhanced ΔERN 3 
amplitudes without influencing task-related behavior. And Ganuschak and 4 
Schiller (2008) found that monetary incentives increased ERN amplitudes and 5 
latencies in a verbal picture-naming task without altering reaction times or error 6 
rates. For researchers concerned with the emotional properties of the ERN, 7 
these studies represent opportune cases for direct replication: they can be well-8 
powered at relatively low sample sizes, they are methodologically simple to 9 
implement, and they can be easily adapted to meet evolving standards in 10 
statistical analyses. 11 
Influential studies that are underpowered and analytically flexible will 12 
continue to be published and cited until power analyses and preregistration 13 
receive wider adoption among peer-reviewed journals. To reduce opportunity 14 
costs from attempting to extend such studies, researchers should examine the 15 
potential replicability of both their own paradigms and those of others when 16 
preparing projects. This can be accomplished in several ways, depending upon 17 
the heterogeneity of the relevant literature. When coupled with bias-correction 18 
tools (Inzlicht, Gervais, & Berkman, 2015), meta-analytic procedures such as the 19 
p-curve (Simonsohn, Nelson, & Simmons, 2014) or mini meta-analysis (Goh, Hall 20 
& Rosenthal, 2016) can be used to determine the evidential value of a study or 21 
line of research. If the supporting evidence is weak, such analyses can reveal 22 
whether certain studies are worth trying to replicate at all. 23 
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Far from being uninteresting or redundant, replication attempts like the 1 
present study can greatly enrich our understanding and application of findings in 2 
psychology. Successive and independent replications elaborate on the 3 
generalizability, conceptual boundaries, and underlying ontology of phenomena 4 
like the ERN and paradigms like the misattribution of arousal. They help confirm 5 
the most plausible components of our theories and paradigms, while directing 6 
attention toward components that may be superfluous, incoherent, or in need of 7 
change. They will also be invaluable in shielding us from unreplicable programs 8 
of research that waste resources, effort, and time. Lastly, as the ERN receives 9 
increasing attention among clinical researchers as a possible biomarker of 10 
pathological anxiety (Kessel et al., 2016; Meyer, 2017), high-powered 11 
replications will be critical for developing an understanding of the signal that can 12 
be translated into clinical practice. By deliberately reserving resources to conduct 13 
replications, researchers will do much to speed up—rather than slow down—the 14 
development of new and effective ways to diagnose and treat mental illness. 15 
Conclusion. 16 
 We conducted a methodologically precise and statistically powerful 17 
replication attempt of Inzlicht & Al-Khindi (2012), using nearly the exact same 18 
materials as the original study; however, our paradigm subsequently failed to 19 
manipulate emotions, and thus the present study cannot address the question of 20 
the ERN’s emotional properties. Further studies with successful manipulations 21 
must be conducted to evaluate the degree to which variance in ERN amplitudes 22 
can be attributed to variance in state and trait emotions.  23 
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Nevertheless, the present study does provide some evidence against 1 
replicability of Inzlicht & Al-Khindi’s (2012) misattribution of arousal paradigm in 2 
concurrently reducing state anxiety and the amplitude of the ERN. Researchers 3 
should be more cautious in considering Inzlicht & Al-Khindi (2012) as evidence 4 
that the ERN has fundamentally emotional properties, and may benefit from 5 
seeking out alternative approaches to misattribution that manipulate emotions 6 
with greater reliability. 7 
In general, researchers have much to gain in pursuing and replicating 8 
paradigms that manipulate emotions while controlling for the cognitive and 9 
behavioral aspects of error monitoring. Establishing what paradigms are 10 
reproducible in this area of the literature—and in psychology in general—will 11 
greatly speed our acquisition of knowledge, especially for those aiming to 12 
translate psychophysiological findings into the clinical domain.    13 
48
MISATTRIBUTION REPLICATION 
Acknowledgements 1 
 2 
We would like to thank all the members of the Toronto Laboratory for Social 3 
Neuroscience for their valuable input throughout the development of this project. 4 
This research will be made possible by grants from Canada’s Natural Sciences 5 
and Engineering Research and Social Sciences and Humanities Research 6 
Councils to MI. 7 
 8 
 9 
  10 
49
MISATTRIBUTION REPLICATION 
References 1 
Aarts, K., De Houwer, J., & Pourtois, G. (2013). Erroneous and correct actions 2 
have a different affective valence: Evidence from ERPs. Emotion, 13(5), 3 
960. 4 
Aarts, K., De Houwer, J., & Pourtois, G. (2013). Erroneous and correct actions 5 
have a different affective valence: Evidence from ERPs. Emotion, 13(5), 6 
960. doi:10.1037/a0032808 7 
Baldwin, S.A., Larson, M.J., Clayson, P.E., 2015. The dependability of 8 
electrophysiological measurements of performance monitoring in a clinical 9 
sample: a generalizability and decision analysis of the ERN and Pe. 10 
Psychophysiology, 52:790–800. doi:10.1111/psyp.12401 11 
Bartholow, B. D., Henry, E. A., Lust, S. A., Saults, J. S., & Wood, P. K. (2012). 12 
Alcohol effects on performance monitoring and adjustment: affect 13 
modulation and impairment of evaluative cognitive control. Journal of 14 
Abnormal Psychology, 121(1), 173. doi:10.1037/a0023664 15 
Bayarri, M. J., & Mayoral, A. M. (2002). Bayesian analysis and design for 16 
comparison of effect-sizes. Journal of Statistical Planning and Inference, 17 
103(1-2), 225–243. doi:10.1016/s0378-3758(01)00223-3 18 
Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: a 19 
practical and powerful approach to multiple testing. Journal of the Royal 20 
Statistical Society, Series B (Methodological), 289-300. 21 
Benjamini, Y., & Yekutieli, D. (2001). The control of the false discovery rate in 22 
multiple testing under dependency. Annals of Statistics, 1165-1188. 23 
50
MISATTRIBUTION REPLICATION 
Botvinick, M. M., Braver, T. S., Barch, D. M., Carter, C. S., & Cohen, J. D. (2001). 1 
Conflict monitoring and cognitive control. Psychological Review, 108(3), 2 
624. doi:10.1037/0033-295X.108.3.624 3 
Brockner, J., & Swap, W. C. (1983). Resolving the relationships between 4 
placebos, misattribution, and insomnia: An individual-differences 5 
perspective. Journal of Personality and Social Psychology, 45(1), 32–42. 6 
doi:10.1037/0022-3514.45.1.32 7 
Brown, J. W., & Braver, T. S. (2005). Learned predictions of error likelihood in the 8 
anterior cingulate cortex. Science, 307(5712), 1118-1121. 9 
doi:10.1126/science.1105783 10 
Button, K. S., Ioannidis, J. P., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. 11 
S., & Munafò, M. R. (2013). Power failure: why small sample size 12 
undermines the reliability of neuroscience. Nature Reviews Neuroscience, 13 
14(5), 365-376. doi:10.1038/nrn3475 14 
Cantor, J. R., Zillmann, D., & Bryant, J. (1975). Enhancement of experienced 15 
sexual arousal in response to erotic stimuli through misattribution of 16 
unrelated residual excitation. Journal of Personality and Social 17 
Psychology, 32(1), 69. doi:10.1037/h0076784 18 
Carpenter, B., Gelman, A., Hoffman, M., Lee, D., Goodrich, B., Betancourt, M., 19 
…, Riddell, A. (n.d.). Stan: a probabilistic programming language. Journal 20 
of Statical Software (in press). 21 
Carver, C. S., & White, T. L. (1994). Behavioral inhibition, behavioral activation, 22 
and affective responses to impending reward and punishment: The 23 
51
MISATTRIBUTION REPLICATION 
BIS/BAS Scales. Journal of Personality and Social Psychology, 67(2), 1 
319–333. doi:10.1037/0022-3514.67.2.319  2 
Chartrand, T. L., & Bargh, J. A. (n.d.). Nonconscious motivations: Their 3 
activation, operation, and consequences. Self and Motivation: Emerging 4 
Psychological Perspectives, 13–41. doi:10.1037/10448-001  5 
Clayson, P. E., & Miller, G. A. (2017a). ERP Reliability Analysis (ERA) Toolbox: 6 
An open-source toolbox for analyzing the reliability of event-related brain 7 
potentials. International Journal of Psychophysiology. doi: 8 
10.1016/j.ijpsycho.2016.10.012 9 
Clayson, P. E., & Miller, G. A. (2017b). Psychometric considerations in the 10 
measurement of event-related brain potentials: Guidelines for 11 
measurement and reporting. International Journal of Psychophysiology. 12 
doi:10.1016/j.ijpsycho.2016.09.005 13 
Cohen, J. (1973). Eta-Squared and Partial Eta-Squared in Fixed Factor ANOVA 14 
Designs. Educational and Psychological Measurement, 33(1), 107-112. 15 
doi:10.1177/001316447303300111 16 
Dehaene, S., Posner, M. I., & Tucker, D. M. (1994). Localization of a neural 17 
system for error detection and compensation. Psychological Science, 303-18 
305. doi:10.1016/j.tics.2006.03.007 19 
Duncan, J. W., & Laird, J. D. (1980). Positive and reverse placebo effects as a 20 
function of differences in cues used in self-perception. Journal of 21 
Personality and Social Psychology, 39(6), 1024–1036. 22 
doi:10.1037/h0077721 23 
52
MISATTRIBUTION REPLICATION 
Edwards, L. J., Muller, K. E., Wolfinger, R. D., Qaqish, B. F., & Schabenberger, 1 
O. (2008). An R2 statistic for fixed effects in the linear mixed model. 2 
Statistics In Medicine, 27, 6137-6157. doi:10.1002/sim.3429 3 
Erdfelder, E., Faul, F., & Buchner, A. (1996). GPOWER: A general power 4 
analysis program. Behavior Research Methods, Instruments, & 5 
Computers, 28(1), 1–11. doi:10.3758/bf03203630 6 
Ganushchak, L. Y., & Schiller, N. O. (2008). Motivation and semantic context 7 
affect brain error-monitoring activity: an event-related brain potentials 8 
study. Neuroimage, 39(1), 395-405. 9 
doi:10.1016/j.neuroimage.2007.09.001 10 
Gehring, W. J., Goss, B., Coles, M. G., Meyer, D. E., & Donchin, E. (1993). A 11 
neural system for error detection and compensation. Psychological 12 
Science, 4(6), 385-390. doi:10.1111/j.1467-9280.1993.tb00586.x 13 
Goh, J. X., Hall, J. A., & Rosenthal, R. (2016). Mini meta‐analysis of your own 14 
studies: Some arguments on why and a primer on how. Social and 15 
Personality Psychology Compass, 10(10), 535-549. 16 
doi:10.1111/spc3.12267 17 
Gratton, G., Coles, M. G., & Donchin, E. (1983). A new method for off-line 18 
removal of ocular artifact. Electroencephalography and clinical 19 
neurophysiology, 55(4), 468-484. doi:10.1016/0013-4694(83)90135-9 20 
Hajcak, G., McDonald, N., & Simons, R. F. (2003). To err is autonomic: Error‐21 
related brain potentials, ANS activity, and post‐ error compensatory 22 
53
MISATTRIBUTION REPLICATION 
behavior. Psychophysiology, 40(6), 895-903. doi:10.1111/1469-1 
8986.00107 2 
Heatherton, T. F., Polivy, J., & Herman, C. P. (1989). Restraint and internal 3 
responsiveness: Effects of placebo manipulations of hunger state on 4 
eating. Journal of Abnormal Psychology, 98(1), 89–92. doi:10.1037/0021-5 
843x.98.1.8 6 
Heerdink, M. W., van Kleef, G. A., Homan, A. C., & Fischer, A. H. (2015). 7 
Emotional expressions as social signals of rejection and acceptance: 8 
evidence from the affect misattribution paradigm. Journal of Experimental 9 
Social Psychology, 56, 60-68. Doi:10.1016/j.jesp.2014.09.004 10 
Holroyd, C. B., & Coles, M. G. (2002). The neural basis of human error 11 
processing: reinforcement learning, dopamine, and the error-related 12 
negativity. Psychological Review, 109(4), 679. doi:10.1037/0033-13 
295X.109.4.679 14 
Huang, Y., & Gong, H. (2018). The Minimal Deviation Effect: Numbers Just 15 
Above a Categorical Boundary Enhance Consumer Desire. Journal of 16 
Consumer Research. doi:10.1093/jcr/ucy048 17 
Inzlicht, M., & Al-Khindi, T. (2012). ERN and the placebo: A misattribution 18 
approach to studying the arousal properties of the error-related negativity. 19 
Journal of Experimental Psychology: General, 141(4), 799. 20 
doi:10.1037/a0027586 21 
Inzlicht, M., Gervais, W., & Berkman, E. (2015). Bias-Correction Techniques 22 
Alone Cannot Determine Whether Ego Depletion is Different from Zero: 23 
54
MISATTRIBUTION REPLICATION 
Commentary on Carter, Kofler, Forster, & McCullough, 2015. Available at 1 
SSRN: http://ssrn.com/abstract=2659409, doi:0.2139/ssrn.2659409 2 
Kessel, E. M., Meyer, A., Hajcak, G., Dougherty, L. R., Torpey-Newman, D. C., 3 
Carlson, G. A., & Klein, D. N. (2016). Transdiagnostic factors and 4 
pathways to multifinality: The error-related negativity predicts whether 5 
preschool irritability is associated with internalizing versus externalizing 6 
symptoms at age 9. Development and Psychopathology, 28(4pt1), 913–7 
926. doi:10.1017/s0954579416000626 8 
Koban, L., & Pourtois, G. (2014). Brain systems underlying the affective and 9 
social monitoring of actions: an integrative review. Neuroscience & 10 
Biobehavioral Reviews, 46, 71-84. doi: 10.1016/j.neubiorev.2014.02.014 11 
Legault, L., & Inzlicht, M. (2013). Self-determination, self-regulation, and the 12 
brain: Autonomy improves performance by enhancing neuroaffective 13 
responsiveness to self-regulation failure. Journal of Personality and Social 14 
Psychology, 105(1), 123. doi:10.1037/a0030426 15 
Little, R.J.A. and Rubin, D.B. (2002). Statistical Analysis with Missing Data, 2nd 16 
edition, New York: John Wiley. doi:10.1002/9781119013563 17 
Luck, S.J., & Gaspelin, N. (2017). How to get statistically significant effects in any 18 
ERP experiment (and why you shouldn’t). Psychophysiology, 54(1), 146-19 
157. doi:10.1111/psyp.12639 20 
Luu, P., Collins, P., & Tucker, D. M. (2000). Mood, personality, and self-21 
monitoring: Negative affect and emotionality in relation to frontal lobe 22 
mechanisms of error monitoring. Journal of Experimental Psychology: 23 
55
MISATTRIBUTION REPLICATION 
General, 129, 43–60. doi:10.1037/0096-3445.129.1.43 1 
Luu, P., Tucker, D. M., Derryberry, D., Reed, M., & Poulsen, C. (2003). 2 
Electrophysiologic responses to errors and feedback in the process of 3 
action regulation. Psychological Science, 14, 47–53. doi:10.1111/1467-4 
9280.01417 5 
Makeig, S., Bell, A. J., Jung, T. P., & Sejnowski, T. J. (1996). Independent 6 
component analysis of electroencephalographic data. Advances in Neural 7 
Information Processing Systems, 145-151. 8 
Marteau, T. M., & Bekker, H. (1992). The development of a six‐item short‐form of 9 
the state scale of the Spielberger State—Trait Anxiety Inventory (STAI). 10 
British Journal of Clinical Psychology, 31(3), 301-306. doi:10.1111/j.2044-11 
8260.1992.tb00997.x 12 
McAuley, E., Duncan, T., & Tammen, V. V. (1989). Psychometric Properties of 13 
the Intrinsic Motivation Inventory in a Competitive Sport Setting: A 14 
Confirmatory Factor Analysis. Research Quarterly for Exercise and Sport, 15 
60(1), 48–58. doi:10.1080/02701367.1989.10607413 16 
Meyer, A. (2017). A biomarker of anxiety in children and adolescents: A review 17 
focusing on the error-related negativity (ERN) and anxiety across 18 
development. Developmental Cognitive Neuroscience, 27, 58–68. 19 
doi:10.1016/j.dcn.2017.08.001 20 
Meyer, A., Weinberg, A., Klein, D. N., & Hajcak, G. (2012). The development of 21 
the error-related negativity (ERN) and its relationship with anxiety: 22 
56
MISATTRIBUTION REPLICATION 
Evidence from 8 to 13 year-olds. Developmental Cognitive Neuroscience, 1 
2(1), 152–161. doi:10.1016/j.dcn.2011.09.005 2 
Moser, J. S., Moran, T. P., Schroder, H. S., Donnellan, M. B., & Yeung, N. 3 
(2013). On the relationship between anxiety and error monitoring: a meta-4 
analysis and conceptual framework. Frontiers in Human Neuroscience, 7. 5 
doi:10.3389/fnhum.2013.00466 6 
Olvet, D. M., & Hajcak, G. (2009). The stability of error‐ related brain activity with 7 
increasing trials. Psychophysiology, 46(5), 957-961. doi:10.1111/j.1469-8 
8986.2009.00848.x 9 
Open Science Collaboration. (2015). Estimating the reproducibility of 10 
psychological science. Science, 349(6251). doi:10.1126/science.aac4716 11 
aac4716 12 
Pailing, P. E., & Segalowitz, S. J. (2004). The effects of uncertainty in error 13 
monitoring on associated ERPs. Brain and Cognition, 56(2), 215-233. 14 
doi:10.1016/j.bandc.2004.06.005 15 
Pashler, H., & Wagenmakers, E.J. (2012). Editors’ introduction to the special 16 
section on replicability in psychological science: A crisis of confidence? 17 
Perspectives on Psychological Science, 7, 528–18 
530.doi:10.1177/1745691612465253 19 
Payne, B. K., Cheng, C. M., Govorun, O., & Stewart, B. D. (2005). An inkblot for 20 
attitudes: Affect misattribution as implicit measurement. Journal of 21 
Personality and Social Psychology, 89(3), 277–293. doi:10.1037/0022-22 
3514.89.3.277 23 
57
MISATTRIBUTION REPLICATION 
Pfabigan, D. M., Pintzinger, N. M., Siedek, D. R., Lamm, C., Derntl, B., & Sailer, 1 
U. (2013). Feelings of helplessness increase ERN amplitudes in healthy 2 
individuals. Neuropsychologia, 51(4), 613–621. 3 
doi:10.1016/j.neuropsychologia.2012.12.008 4 
Pourtois, G., Vocat, R., N’diaye, K., Spinelli, L., Seeck, M., & Vuilleumier, P. 5 
(2010). Errors recruit both cognitive and emotional monitoring systems: 6 
simultaneous intracranial recordings in the dorsal anterior cingulate gyrus 7 
and amygdala combined with fMRI. Neuropsychologia, 48(4), 1144-1159. 8 
doi:10.1016/j.neuropsychologia 9 
Proudfit, G. H., Inzlicht, M., & Mennin, D. S. (2013). Anxiety and error monitoring: 10 
the importance of motivation and emotion. Frontiers in Human 11 
Neuroscience, 7, 636. doi:10.3389/fnhum.2013.00636 12 
Quené, H., & van der Bergh, H. (2004). On multi-level modeling of data from 13 
repeated measures designs: a tutorial. Speech Communication, 43(1-2), 14 
103-121. doi:10.1016/j.specom.2004.02.004 15 
Reisenzein, R. (1983). The Schachter theory of emotion: Two decades later. 16 
Psychological Bulletin, 94(2), 239–264. doi:10.1037/0033-2909.94.2.239 17 
Ridderinkhof, K. R., de Vlugt, Y., Bramlage, A., Spaan, M., Elton, M., Snel, J., & 18 
Band, G. P. (2002). Alcohol consumption impairs detection of performance 19 
errors in mediofrontal cortex. Science, 298(5601), 2209-2211. doi: 20 
10.1126/science.1076929 21 
58
MISATTRIBUTION REPLICATION 
Riesel, A., Weinberg, A., Endrass, T., Kathmann, N., & Hajcak, G. (2012). 1 
Punishment has a lasting impact on error‐ related brain activity. 2 
Psychophysiology, 49(2), 239-247. doi:10.1111/j.1469-8986.2011.01298.x 3 
Rodilla, C.C., Beauducel, A., & Leue, A. (2015). Misattribution of Anxious Arousal 4 
Reduces the Effect of Trait-Anxiety on the ERN. Poster session presented 5 
at the 55th Annual Meeting of the Society for Psychophysiological 6 
Research, Seattle, OR. 7 
Rodilla, C.C., Beauducel, A., & Leue, A. (2016). Error-Related Negativity and the 8 
Misattribution of State-Anxiety Following Errors: On the Reproducibility of 9 
Inzlicht and Al-Khindi (2012). Frontiers in Human Neuroscience, 10, 475. 10 
doi: 10.3389/fnhum.2016.00475 11 
Ross, L., Rodin, J., & Zimbardo, P. G. (1969). Toward an attribution therapy: The 12 
reduction of fear through induced cognitive–emotional misattribution. 13 
Journal of Personality and Social Psychology, 12, 279–288. 14 
doi:10.1037/h0027800 15 
Saunders, B., Lin, H., Milyavskaya, M., & Inzlicht, M. (2017). The emotive nature 16 
of conflict monitoring in the medial prefrontal cortex. International Journal 17 
of Psychophysiology, 119, 31-40. doi:10.1016/j.ijpsycho.2017.01.004 18 
Saunders, B., Rodrigo, A. H., & Inzlicht, M. (2016). Mindful Awareness of 19 
Feelings Increases Neural Performance Monitoring. Cognitive, Affective, & 20 
Behavioral Neuroscience, 16, 93-105. doi:10.3758/s13415-015-0375-2 21 
59
MISATTRIBUTION REPLICATION 
Schachter, S., & Singer, J. (1962). Cognitive, social, and physiological 1 
determinants of emotional state. Psychological Review, 69(5), 379–399. 2 
doi:10.1037/h0046234 3 
Schwarz, N., & Clore, G. L. (1983). Mood, misattribution, and judgments of well-4 
being: Informative and directive functions of affective states. Journal of 5 
Personality and Social Psychology, 45(3), 513–523. doi:10.1037/0022-6 
3514.45.3.513 7 
Simonsohn, U., Nelson, L. D., & Simmons, J. P. (2014). P-curve and effect size: 8 
Correcting for publication bias using only significant results. Perspectives 9 
on Psychological Science, 9(6), 666-681. doi:10.1177/1745691614553988 10 
Spielberger, C. D. (2010). State‐ Trait Anxiety Inventory. John Wiley & Sons, Inc. 11 
Spunt, R. P., Lieberman, M. D., Cohen, J. R., & Eisenberger, N. I. (2012). The 12 
Phenomenology of Error Processing: The Dorsal ACC Response to Stop-13 
signal Errors Tracks Reports of Negative Affect. Journal of Cognitive 14 
Neuroscience, 24(8), 1753–1765. doi:10.1162/jocn_a_00242 15 
Storms, M. D., & Nisbett, R. E. (1970). Insomnia and the attribution process. 16 
Journal of Personality and Social Psychology, 16, 319–17 
328.doi:10.1037/h0029835 18 
Team, S.D. (2016). CmdStan: the command-line interface to Stan, version 19 
2.10.0. Retrieved from http://mc-stan.org/. 20 
Van Veen, V., & Carter, C. S. (2002). The anterior cingulate as a conflict monitor: 21 
fMRI and ERP studies. Physiology & Behavior, 77(4), 477-482. 22 
doi:10.1016/S0031-9384(02)00930-7 23 
60
MISATTRIBUTION REPLICATION 
Yeung, V., Sharpe, L., Glozier, N., Hackett, M. L., & Colagiuri, B. (2017). A 1 
systematic review and meta-analysis of placebo versus no treatment for 2 
insomnia symptoms. Sleep Medicine Reviews, 38, 17-27. 3 
doi:10.1016/j.smrv.2017.03.006 4 
Weinberg, A., Riesel, A., & Hajcak, G. (2012). Integrating multiple perspectives 5 
on error-related brain activity: the ERN as a neural indicator of trait 6 
defensive reactivity. Motivation and Emotion, 36(1), 84-100. 7 
doi:10.1007/s11031-011-9269-y 8 
Weinberg, A., Meyer, A., Hale-Rude, E., Perlman, G., Kotov, R., Klein, D. N., & 9 
Hajcak, G. (2016). Error-related negativity (ERN) and sustained threat: 10 
Conceptual framework and empirical evaluation in an adolescent sample. 11 
Psychophysiology, 53(3), 372–385. doi:10.1111/psyp.12538 12 
Weinberg, A., Olvet, D. M., & Hajcak, G. (2010). Increased error-related brain 13 
activity in generalized anxiety disorder. Biological Psychology, 85(3), 472–14 
480. doi:10.1016/j.biopsycho.2010.09.011 15 
Xiao, Z., Wang, J., Zhang, M., Li, H., Tang, Y., Wang, Y., … Fromson, J. A. 16 
(2011). Error-related negativity abnormalities in generalized anxiety 17 
disorder and obsessive–compulsive disorder. Progress in Neuro-18 
Psychopharmacology and Biological Psychiatry, 35(1), 265–272. 19 
doi:10.1016/j.pnpbp.2010.11.022 20 
Yeung, N., Botvinick, M. M., & Cohen, J. D. (2004). The neural basis of error 21 
detection: conflict monitoring and the error-related negativity. 22 
Psychological Review, 111(4), 931. 23 
61
MISATTRIBUTION REPLICATION 
Zanna, M. P., & Cooper, J. (1974). Dissonance and the pill: An attribution 1 
approach to studying the arousal properties of dissonance. Journal of 2 
Personality and Social Psychology, 29, 703–709. doi:10.1037/h0036651 3 
62
